Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Open-Label Study of Oral Treprostinil in Digital Ulcers

ClinicalTrials.gov ID: NCT00848107

Public ClinicalTrials.gov record NCT00848107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.

Study identification

NCT ID
NCT00848107
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
United Therapeutics
Industry
Enrollment
115 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Jun 18, 2024

2009 – 2011

United States locations

U.S. sites
22
U.S. states
20
U.S. cities
22
Facility City State ZIP Site status
University of Alabama - Birmingham - Arthritis Clinical Intervention Program Birmingham Alabama 35294-7201 —
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
UCLA Los Angeles California 90095-1670 —
Barbara Davis Centre Aurora Colorado 80045 —
University of Connecticut Health Center Farmington Connecticut 06030-1310 —
Georgetown University - Dept. of Medicine/Rheumatology Washington D.C. District of Columbia 20007 —
Northwestern University - Feinberg School of Medicine Chicago Illinois 60611 —
Johns Hopkins University - Division of Rheumatology Baltimore Maryland 21224 —
Boston University School of Medicine Boston Massachusetts 02118-2526 —
University of Michigan - Scleroderma Program Ann Arbor Michigan 48106 —
University of Minnesota Minneapolis Minnesota 55455 —
UMDNJ Clinical Research Center New Brunswick New Jersey 08903 —
North Shore - LIJ Health System Lake Success New York 11042 —
The Hospital for Special Surgery New York New York 10021 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
University of Toledo Toledo Ohio 43614 —
University of Pittsburgh Pittsburgh Pennsylvania 15261 —
Medical University of South Carolina Charleston South Carolina 29425-8900 —
University of Texas - Houston Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
Virginia Mason Medical Seattle Washington 98101 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00848107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2024 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00848107 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →